Clinical significance of clinicopathological features in predicting surgical treatment and risk of complications in renal cancer with venous tumor thrombosis
R. N. Komarov, L. Rapoport, M. Shao, D. O. Korolev, M. He, R. I. Slusarenko, I. B. Lutsenko
{"title":"Clinical significance of clinicopathological features in predicting surgical treatment and risk of complications in renal cancer with venous tumor thrombosis","authors":"R. N. Komarov, L. Rapoport, M. Shao, D. O. Korolev, M. He, R. I. Slusarenko, I. B. Lutsenko","doi":"10.17650/2070-9781-2023-24-4-128-134","DOIUrl":null,"url":null,"abstract":"Aim. To study and analyze the surgical results and prognostic factors accompanying radical nephrectomy combined with venous thrombectomy in renal cancer patients with venous tumor thrombosis.Materials and methods. Retrospective analysis of clinical data of patients with renal cancer and venous tumor thrombosis who underwent surgical treatment at the Clinic of Cardiovascular Surgery and the Clinic of Urology of the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University) from May 2010 to February 2023. Kaplan–Meier analysis was used to obtain overall survival curves and log-rank tests were used for statistical comparisons; Cox regression models were used for multivariate analysis of survival and complications to find independent risk factors affecting prognosis.Results. A total of 42 patients were included, 15 patients with grade 0–II tumor thrombosis and 27 patients with grade III–IV thrombosis. There were 3 perioperative deaths. The 5-year postoperative survival rate of patients was 68 %. Cox regression analysis: stage Т: HR = 0.515, 95 % confidential interval (CI) 0.111–2.393, p = 0.397; stage N: HR = 1.430, 95 % CI 0.380–5.457, p = 0.592; stage М: HR = 3.312, 95 % CI 0.811–4.561, p = 0,138; time of operation: HR = 1.001, 95 % CI 0.997–1.004, p = 0.771.Conclusion. Kidney cancer patients with venous tumor thrombosis have better surgical treatment results, which may significantly improve their prognosis compared with non-operated patients. Stage N and stage M were important factors directly affecting patients’ survival (HR >1), but the level of tumor thrombosis could not be a factor affecting patients’ survival (HR = 1), but p >0.05, so it was not statistically significant. The level of tumor thrombosis and the duration of surgery affect the intraoperative blood loss, and the greater the intraoperative blood loss, the higher the stage of early postoperative complications and the worse the patient’s prognosis.","PeriodicalId":368206,"journal":{"name":"Andrology and Genital Surgery","volume":"20 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Andrology and Genital Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2070-9781-2023-24-4-128-134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Aim. To study and analyze the surgical results and prognostic factors accompanying radical nephrectomy combined with venous thrombectomy in renal cancer patients with venous tumor thrombosis.Materials and methods. Retrospective analysis of clinical data of patients with renal cancer and venous tumor thrombosis who underwent surgical treatment at the Clinic of Cardiovascular Surgery and the Clinic of Urology of the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University) from May 2010 to February 2023. Kaplan–Meier analysis was used to obtain overall survival curves and log-rank tests were used for statistical comparisons; Cox regression models were used for multivariate analysis of survival and complications to find independent risk factors affecting prognosis.Results. A total of 42 patients were included, 15 patients with grade 0–II tumor thrombosis and 27 patients with grade III–IV thrombosis. There were 3 perioperative deaths. The 5-year postoperative survival rate of patients was 68 %. Cox regression analysis: stage Т: HR = 0.515, 95 % confidential interval (CI) 0.111–2.393, p = 0.397; stage N: HR = 1.430, 95 % CI 0.380–5.457, p = 0.592; stage М: HR = 3.312, 95 % CI 0.811–4.561, p = 0,138; time of operation: HR = 1.001, 95 % CI 0.997–1.004, p = 0.771.Conclusion. Kidney cancer patients with venous tumor thrombosis have better surgical treatment results, which may significantly improve their prognosis compared with non-operated patients. Stage N and stage M were important factors directly affecting patients’ survival (HR >1), but the level of tumor thrombosis could not be a factor affecting patients’ survival (HR = 1), but p >0.05, so it was not statistically significant. The level of tumor thrombosis and the duration of surgery affect the intraoperative blood loss, and the greater the intraoperative blood loss, the higher the stage of early postoperative complications and the worse the patient’s prognosis.
目的研究和分析伴有静脉肿瘤血栓的肾癌患者根治性肾切除术联合静脉血栓切除术的手术效果和预后因素。回顾性分析2010年5月至2023年2月期间在俄罗斯卫生部莫斯科第一国立医科大学(谢切诺夫大学)心血管外科诊所和泌尿外科诊所接受手术治疗的肾癌合并静脉瘤血栓患者的临床数据。采用卡普兰-梅耶尔分析法得出总生存率曲线,并用对数秩检验进行统计比较;采用考克斯回归模型对生存率和并发症进行多变量分析,以找出影响预后的独立风险因素。共纳入42例患者,其中15例为0-II级肿瘤血栓形成,27例为III-IV级血栓形成。围手术期死亡 3 例。患者术后5年生存率为68%。Cox回归分析:Т期:HR=0.515,95%保密区间(CI)0.111-2.393,P=0.397;N期:HR=1.430,95% CI 0.380-5.457,P=0.592;М期:HR=3.312,95% CI 0.380-5.457,P=0.592:HR=3.312,95 % CI 0.811-4.561,p=0,138;手术时间:HR=1.001,95 % CI 0.997-1.004,P=0.771。肾癌静脉瘤血栓患者的手术治疗效果更好,与未手术患者相比,可显著改善预后。N期和M期是直接影响患者生存期的重要因素(HR>1),但肿瘤血栓水平不能成为影响患者生存期的因素(HR=1),但P>0.05,因此无统计学意义。肿瘤血栓形成程度和手术时间影响术中失血量,术中失血量越大,术后早期并发症发生率越高,患者预后越差。